Evolving Concepts in the Management of Lobular Neoplasia

View More View Less
  • a From the Department of Surgery, Section of Surgical Oncology, University of Washington, Seattle, Washington, and Department of Radiology, University of Washington, Seattle Cancer Care Alliance, Seattle, Washington.

Lobular neoplasia broadly defines the spectrum of changes within the lobule, ranging from atypical lobular hyperplasia (ALH) to lobular carcinoma in situ (LCIS). This continuum of lesions is associated with an increased risk for developing subsequent invasive breast cancer, with the magnitude of that risk corresponding to the degree of proliferative change. The associated risk for developing invasive breast cancer after a diagnosis of lobular neoplasia is multicentric, bilateral, and equal in both breasts. Lobular neoplasia itself may transform into invasive carcinoma, although the frequency of this occurrence is unknown. Thus, lobular neoplasia is a risk factor for invasive breast cancer and may be a precursor lesion in unusual circumstances. The management of ALH and LCIS depends on the setting in which they are encountered. When ALH and LCIS are diagnosed after core needle breast biopsy, wire localization for surgical excision is required for definitive diagnosis because rates of histologic underestimation approach those of atypical ductal hyperplasia (ADH). When diagnosed on surgical biopsy, ALH and LCIS generally do not require further intervention, even when present at a surgical margin. However, bilateral breast cancer risk must be considered, especially when patients have a family history of breast cancer. In selected situations, bilateral prophylactic mastectomy with or without reconstruction may be considered when atypical hyperplasia or LCIS is diagnosed. Although this reduces risk for developing subsequent breast carcinoma by 90%, patients selected for prophylactic mastectomy represent a small subgroup of lobular neoplasia patients and generally have other risk factors, such as strong family history or evidence of genetic predisposition.

Correspondence: Benjamin O. Anderson, MD, Department of Surgery, Box 356410, University of Washington, Seattle, WA 98195. E-mail: banderso@u.washington.edu
  • 1.

    Foote FJ, Stewart F. Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol 1941;17:491496.

  • 2.

    Carson W, Sanchez-Forgach E, Stomper P et al.. Lobular carcinoma in situ: observation without surgery as an appropriate therapy. Ann Surg Oncol 1994;1:141146.

    • Search Google Scholar
    • Export Citation
  • 3.

    Cornil AV. Contributions a l'histoire du developpement histologique des tumeurs epitheliales (sqirrhe, encephaloide, etc.). J Anat Physiol 1865;2:266276.

    • Search Google Scholar
    • Export Citation
  • 4.

    Ewing J. Neoplastic Diseases. Philadelphia: W.B. Saunders, 1919.

  • 5.

    Cheatle GL, Cutler M. Tumours of the Breast. London, UK: Edward Arnold & Co.; 1931.

  • 6.

    Broders AC. Carcinoma in situ contrasted with benign penetrating epithelium. JAMA 1932;99:16701674.

  • 7.

    Godwin JT. Chronology of lobular carcinoma of the breast: report of a case. Cancer 1952;5:259266.

  • 8.

    Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978;42:737769.

  • 9.

    Lakhani SR, Collins N, Sloane J, Stratton M. Loss of heterozygosity in lobular carcinoma in situ of the breast. J Clin Pathol (Mol Pathol) 1995;48:M74M78.

    • Search Google Scholar
    • Export Citation
  • 10.

    Berx G, Cleton-Jansen AM, Strumane K et al.. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996;13:19191925.

    • Search Google Scholar
    • Export Citation
  • 11.

    Frost AR, Tsangaris TN, Silverberg SG. Pleomorphic lobular carcinoma in situ. Pathol Case Rev 1996;1:2731.

  • 12.

    Middleton L, Palacios D, Bryant B et al.. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 2000;24:16501656.

    • Search Google Scholar
    • Export Citation
  • 13.

    Rosen PP, Lieberman PH, Braun DWJ et al.. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978;2:225251.

    • Search Google Scholar
    • Export Citation
  • 14.

    Bodian CA, Perzin KH, Lattes R et al.. Prognostic significance of benign proliferative breast disease. Cancer 1993;71:38963907.

  • 15.

    Fisher B, Costantino JP, Wickerham DL et al.. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:13711388.

    • Search Google Scholar
    • Export Citation
  • 16.

    Carlson RW, Anderson BO, Burstein HJ et al.. NCCN Breast Cancer Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2005;3:238289.

  • 17.

    Andersen J, Vendelboe M. Cytoplasmic mucous globules in lobular carcinoma in situ. Diagnosis and prognosis. Am J Surg Pathol 1981;5:251255.

    • Search Google Scholar
    • Export Citation
  • 18.

    Barwick K, Kashgarian M, Rosen P. ``Clear cell'' change within duct and lobular epithelium of the human breast. Pathol Annu 1982;17:319328.

  • 19.

    Breslow A, Brancaccio M. Intracellular mucin production by lobular breast carcinoma cells. Arch Pathol Lab Med 1976;100:620621.

  • 20.

    Eusebi V, Betts C, Haagensen D et al.. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic and ultrastructural study. Hum Pathol 1984;15:134140.

    • Search Google Scholar
    • Export Citation
  • 21.

    Gad A, Azzopardi J. Lobular carcinoma of the breast: a special variant of mucin-secreting carcinoma. J Clin Pathol 1975;28:711716.

  • 22.

    Rosen P. Lobular carcinoma and hyperplasia. In: Rosen P, ed. Breast Pathology. Philadelphia: Lippincott-Raven; 1997:507544.

  • 23.

    Acs G, Lawton T, Rebbeck T et al.. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001;115:8598.

    • Search Google Scholar
    • Export Citation
  • 24.

    Bentz J, Yassa N, Clayton F. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Modern Pathol 1998;11:814822.

    • Search Google Scholar
    • Export Citation
  • 25.

    Bodis S, Siziopikou KP, Schnitt SJ et al.. Extensive apoptosis in ductal carcinoma in situ of the breast. Cancer 1996;77:18311935.

  • 26.

    Jacobs T, Pliss N, Kouria G, Schnitt S. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001;25:229236.

    • Search Google Scholar
    • Export Citation
  • 27.

    Maluf H, Swanson P, Koerner F. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol 2001;25:237244.

    • Search Google Scholar
    • Export Citation
  • 28.

    Schnitt S, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol 1999;16:209223.

  • 29.

    Tavassoli F. Lobular neoplasia. In: Tavassoli F, ed. Pathology of the Breast, 2nd ed. Stamford: Appleton & Lange; 1999:373400.

  • 30.

    Sapino A, Frigerio A, Peterse J et al.. Mammographically detected in situ lobular carcinoma of the breast. Virchows Arch 2000;436:421430.

  • 31.

    Fisher ER, Costantino J, Fisher B et al.. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer 1996;78:14031416.

    • Search Google Scholar
    • Export Citation
  • 32.

    De Leeuw W, Berx G, Vos C et al.. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997;183:404411.

    • Search Google Scholar
    • Export Citation
  • 33.

    Gamallo C, Palacios J, Suarez A et al.. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993;142:987993.

    • Search Google Scholar
    • Export Citation
  • 34.

    Kanai Y, Oda T, Tsuda H et al.. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Jpn J Cancer Res 1994;85:10351039.

    • Search Google Scholar
    • Export Citation
  • 35.

    Moll R, Mitze M, Frixen U, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993;143:17311742.

    • Search Google Scholar
    • Export Citation
  • 36.

    Vos C, Cleton-Jansen A, Berx G et al.. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997;76:11311133.

    • Search Google Scholar
    • Export Citation
  • 37.

    Gupta S, Douglas-Jones A, Jasani B et al.. E-cadherin (E-cad) expression in duct carcinoma in situ (DCIS) of the breast. Virchows Arch 1997;430:2328.

    • Search Google Scholar
    • Export Citation
  • 38.

    Kashiwaba M, Tamura G, Suzuki Y et al.. Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast. Jpn J Cancer Res 1995;86:10541059.

    • Search Google Scholar
    • Export Citation
  • 39.

    Lishman S, Lakhani S. Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology. Histopathology 1999;35:195200.

    • Search Google Scholar
    • Export Citation
  • 40.

    Li CI, Anderson BO, Daling JR, Moe RE. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat 2002;75:259268.

  • 41.

    Anderson BO, Li CI, Lawton TJ et al.. Clinical management of lobular carcinoma in situ. In: Singletary SE, Robb GL, Hortobagyi GN, eds. Advanced Therapy of Breast Disease, 2nd ed. Hamilton, Ontario, Canada: B.C. Decker; 2004:269280.

    • Search Google Scholar
    • Export Citation
  • 42.

    Li CI, Weiss NS, Stanford JL, Daling JR. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 2000;88:25702577.

    • Search Google Scholar
    • Export Citation
  • 43.

    Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic–pathologic correlation. Am J Roentgenol 2001;176:12551259.

    • Search Google Scholar
    • Export Citation
  • 44.

    Muir J. The evolution of carcinoma of the mamma. J Pathol Bacteriol 1941;52:155172.

  • 45.

    Rosen PP, Senie R, Schottenfeld D, Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg 1979;189:377382.

    • Search Google Scholar
    • Export Citation
  • 46.

    Swain SM. Overview and treatment of lobular carcinoma in situ. In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins; 1997:595609.

    • Search Google Scholar
    • Export Citation
  • 47.

    Beute BJ, Kalisher L, Hutter RVP. Lobular carcinoma in situ of the breast: clinical, pathologic and mammographic features. Am J Roentgenol 1991;157:257265.

    • Search Google Scholar
    • Export Citation
  • 48.

    Page DL, Kidd TE Jr, Dupont WD et al.. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991;22:12321239.

    • Search Google Scholar
    • Export Citation
  • 49.

    Haagensen CD. Lobular neoplasia (lobular carcinoma in situ). In: Haagensen CD, ed. Diseases of the Breast. Philadelphia: W.B. Saunders; 1986:192241.

    • Search Google Scholar
    • Export Citation
  • 50.

    Anderson JA. Multicentric and bilateral appearance of lobular carcinoma in situ of the breast. Acta Pathol Microbiol Scand [A] 1974;82:730734.

    • Search Google Scholar
    • Export Citation
  • 51.

    Wheeler JE, Enterline HT, Roseman JM et al.. Lobular carcinoma in situ of the breast: long-term followup. Cancer 1974;34:554563.

  • 52.

    Eusebi V, Magalhaes F, Azzopardi JG. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Human Pathol 1992;23:655662.

    • Search Google Scholar
    • Export Citation
  • 53.

    Weidner N, Semple JP. Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 1992;23:11671171.

  • 54.

    Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group [see comments]. Lancet 1998;351:14511467.

    • Search Google Scholar
    • Export Citation
  • 55.

    Powles T, Eeles R, Ashley S et al.. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet 1998;352:98101.

    • Search Google Scholar
    • Export Citation
  • 56.

    Veronesi U, Maisonneuve P, Costa A et al.. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study [see comments]. Lancet 1998;352:9397.

    • Search Google Scholar
    • Export Citation
  • 57.

    Anderson BO, Lawton TJ, Rinn K et al.. Lobular carcinoma in situ. In: Silverstein MJ, ed. Ductal Carcinoma In Situ of the Breast, 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 2002: 615634.

    • Search Google Scholar
    • Export Citation
  • 58.

    Chlebowski RT, Collyar DE, Somerfield MR, Pfister DG. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. J Clin Oncol 1999;17:19391955.

    • Search Google Scholar
    • Export Citation
  • 59.

    O'Driscoll D, Britton P, Bobrow L et al.. Lobular carcinoma in situ on core biopsy—what is the clinical significance? Clin Radiol 2001;56:216220.

  • 60.

    Liberman L, Sama M, Susnik B et al.. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings [see comments]. AJR Am J Roentgenol 1999;173:291299.

    • Search Google Scholar
    • Export Citation
  • 61.

    Middleton LP, Grant S, Stephens T et al.. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol 2003;16:120129.

    • Search Google Scholar
    • Export Citation
  • 62.

    Foster MC, Helvie MA, Gregory NE et al.. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology 2004;231:813819.

    • Search Google Scholar
    • Export Citation
  • 63.

    Carlson RW, Anderson BO, Bonaccio E et al.. NCCN Breast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology 1.2004. Complete Library of NCCN Clinical Practice Guidelines in Oncology CD-ROM. Jenkintown, PA: National Comprehensive Cancer Network; 2005. To view the most recent version of the guidelines, go to www.nccn.org.

    • Search Google Scholar
    • Export Citation
  • 64.

    Moran M, Haffty BG. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy. Int J Radiat Oncol Biol Phys 1998;40:353358.

    • Search Google Scholar
    • Export Citation
  • 65.

    Abner AL, Connolly JL, Recht A et al.. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 2000;88:10721077.

    • Search Google Scholar
    • Export Citation
  • 66.

    Fowble B, Hanlon AL, Patchefsky A et al.. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. Int J Radiat Oncol Biol Phys 1998;42:105115.

    • Search Google Scholar
    • Export Citation
  • 67.

    Sasson AR, Fowble B, Hanlon AL et al.. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 2001;91:18621869.

    • Search Google Scholar
    • Export Citation
  • 68.

    Lehman CD, Blume JD, Weatherall P et al.. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005;103:18981905.

    • Search Google Scholar
    • Export Citation
  • 69.

    Hartmann LC, Schaid DJ, Woods JE et al.. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:7784.

    • Search Google Scholar
    • Export Citation
  • 70.

    Fisher B, Dignam J, Wolmark N et al.. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353:19932000.

    • Search Google Scholar
    • Export Citation
  • 71.

    Fisher B, Land S, Mamounas E et al.. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. 2nd ed. Philadelphia: Lippincott Williams and Wilkins, 2002: 432446.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 368 108 7
PDF Downloads 203 60 4
EPUB Downloads 0 0 0